back to Australia directory
australia clinical guidance

Vulvovaginal candidiasis (thrush)

A detailed Australian summary of vulvovaginal candidiasis (thrush), with source-attributed priorities, a practical workflow, safety escalation and state or territory implementation boundaries.

JurisdictionAustralia
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Australia
This is an iatroX educational summary of named Australia sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Apply current TGA product information, PBS restrictions, state or territory law, local referral criteria, formulary and antimicrobial policy. A national recommendation does not create uniform service access.

Scope

Confirm itch, soreness and typical discharge while considering dermatitis, bacterial vaginosis, STI, vulval dermatosis and non-albicans Candida. Use microscopy or culture for recurrent, severe, atypical or treatment-resistant symptoms rather than repeated empirical antifungal courses. This summary is limited to the population, decisions and escalation boundaries stated in the named source.
sources for this section:Australian STI Guidelines

The Bottom Line

  • Confirm itch, soreness and typical discharge while considering dermatitis, bacterial vaginosis, STI, vulval dermatosis and non-albicans Candida.
  • Use microscopy or culture for recurrent, severe, atypical or treatment-resistant symptoms rather than repeated empirical antifungal courses.
  • Microscopy showing yeast supports diagnosis, but Candida culture without symptoms can reflect colonisation and does not mandate treatment.
  • Treat uncomplicated disease with an Australian-recommended topical or oral option, checking pregnancy and interaction restrictions.
sources for this section:Australian STI Guidelines

Practical clinical workflow

1

Topic-specific assessment action

Confirm itch, soreness and typical discharge while considering dermatitis, bacterial vaginosis, STI, vulval dermatosis and non-albicans Candida.
2

Topic-specific diagnostic action

Treat uncomplicated disease with an Australian-recommended topical or oral option, checking pregnancy and interaction restrictions.
3

Topic-specific management action

Recurrent candidiasis requires confirmation, diabetes and immunosuppression review and an induction鈥搈aintenance plan guided by species and susceptibility.
4

Topic-specific follow-through

Pregnancy generally requires a topical azole pathway and avoidance of non-approved systemic exposure.
sources for this section:Australian STI Guidelines

Safety boundaries and escalation

  • Ulceration, severe swelling, systemic illness, pelvic pain, pregnancy concern or persistent unexplained vulval symptoms warrants prompt specialist assessment.
  • Vulval skin care should avoid soaps and irritants and can reduce persistent burning after microbiological cure.
sources for this section:Australian STI Guidelines

Implementation

The named source is national or binational guidance used in Australia, but referral access, public-health directions, formularies and funded services can still differ by state, territory and health service. Check current TGA product information for medicines. Offer culturally safe care and use the NACCHO鈥揜ACGP National Guide where Aboriginal and Torres Strait Islander preventive or chronic-care recommendations differ.
sources for this section:Australian STI Guidelines

Clinical use boundary

This independently written summary is not an official guideline. Check the linked source version, current TGA-approved product information where medicines are involved, and the applicable state, territory and local pathway at the point of care.

sources for this section:Australian STI Guidelines

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Australasian Society for HIV, Viral Hepatitis and Sexual Health MedicineAustralian STI Management Guidelines for Use in Primary CareLiving web guideline checked 2026-08-20 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the Australia question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.